1British Biotech Pharmaceuticals Ltd, Oxford, UK. whittaker@britbio.co.uk
Researchers are developing new compound libraries to inhibit protease enzymes. Novel solid-phase linkers and structure-based design are key to creating effective protease inhibitors.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: